US Patent 11129872 Methods of making and using soluble MHC molecules
Patent 11129872 was granted and assigned to Kite Pharma, Inc. on September, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 11, 2017
Date of Patent
September 28, 2021
Patent Applicant
Patent Application Number
20170811
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11129872 Methods of making and using soluble MHC molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.